Patents by Inventor Dawn Adkin

Dawn Adkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lisinopril compositions with an ingestible event marker
    Patent number: 11684605
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: June 27, 2023
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • LISINOPRIL COMPOSITIONS WITH AN INGESTIBLE EVENT MARKER
    Publication number: 20220079919
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Application
    Filed: October 6, 2021
    Publication date: March 17, 2022
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • Lisinopril compositions with an ingestible event marker
    Patent number: 11166939
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: November 9, 2021
    Assignee: OTSUKA PHARMACEUTICAL CO. LTD
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • LISINOPRIL COMPOSITIONS WITH AN INGESTIBLE EVENT MARKER
    Publication number: 20190216776
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Application
    Filed: April 25, 2018
    Publication date: July 18, 2019
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin